Cuvposa Approval History
- FDA approved: Yes (First approved July 28th, 2010)
- Brand name: Cuvposa
- Generic name: glycopyrrolate
- Dosage form: Oral Solution
- Company: Shionogi Pharma Inc.
- Treatment for: Chronic Drooling in Children
Cuvposa (glycopyrrolate) oral solution is an anticholinergic for the treatment of chronic severe drooling caused by neurologic disorders in children.
Development History and FDA Approval Process for Cuvposa
|Jul 29, 2010||FDA Approves Cuvposa for Chronic Drooling in Children|
|Sep 29, 2009||Sciele Pharma Submits New Drug Application to FDA for Glycopyrrolate Oral Solution, a Treatment for Chronic, Moderate-to-Severe Drooling in Pediatric Patients|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.